<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83041">
  <stage>Registered</stage>
  <submitdate>5/08/2008</submitdate>
  <approvaldate>25/08/2008</approvaldate>
  <actrnumber>ACTRN12608000421336</actrnumber>
  <trial_identification>
    <studytitle>Randomised controlled trial of routine replacement of peripheral cannulae versus removal on clinical indication</studytitle>
    <scientifictitle>Randomised controlled trial of routine replacement of peripheral cannulae versus removal on clinical indication for the prevention of phlebitis</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Phlebitis associated with intravenous cannulation</healthcondition>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Studies of infection and infectious agents</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Generic hospital patients from medical/surgical/oncology wards with a peripheral intravenous device (IV) will have this used for 72-96 hours. The IV will then be removed and a new IV will be inserted into a different vein. This will continue for the course of treatment (e.g. the course of antibiotics or rehydration).</interventions>
    <comparator>Intravenous cannulae (IVs) are left in situ unless clinically indicated for removal (phlebitis, suspected infection, malfunction, tretament ceased). The IV is used for the course of treatment (e.g. course of antibiotics). There is no prescribed duration of IV dwell time.</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Phlebitis: Phlebitis during catheterisation or up to 48 hours after catheter removal. Phlebitis defined as 2 or more of: pain, tenderness, erythema, swelling, purulence, and/or palpable venous cord.</outcome>
      <timepoint>Daily whilst cannulae is in situ</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Catheter Related Bloodstream Infection (CRBSI): Bacteremia/fungemia with 1 positive blood culture obtained from a peripheral vein, clinical manifestations of infections (i.e.fever, chills, and/or hypotension), and no apparent source for the BSI except the catheter. One of the following should be present: a positive semiquantitative (&gt;15 CFU/catheter segment) or quantitative (&gt;103 Colony Forming Units/catheter segment catheter)
culture whereby the same organism (species and antibiogram) is isolated from the catheter segment and peripheral blood; simultaneous quantitative blood cultures with a &gt;5:1 ratio IV versus peripheral; differential period of IV culture versus peripheral blood culture positivity of &gt;2 hours.</outcome>
      <timepoint>Daily whilst cannulae in situ</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Peripheral cannulae in situ as part of routine clinical care for 3 days, written consent</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Current bloodstream infection, immunosuppressed, planned intravenous device (IV) removal within 24 hours</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Study group is concealed until randomisation. A telephone service is used to conceal.</concealment>
    <sequence>Computer generated</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/02/2007</anticipatedstartdate>
    <actualstartdate>20/05/2008</actualstartdate>
    <anticipatedenddate />
    <actualenddate>9/09/2009</actualenddate>
    <samplesize>754</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>QLD</recruitmentstate>
    <hospital>Royal Brisbane &amp; Womens Hospital - Herston</hospital>
    <postcode>4029 - Royal Brisbane Hospital</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Griffith University</primarysponsorname>
    <primarysponsoraddress>Research Centre for Clinical and Community Practice Innovation
Nathan Campus, Kessels Road QLD 4111</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Clifford Craig Medical Research Trust</fundingname>
      <fundingaddress>PO Box 1963
Launceston TAS 7250</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Launceston General Hospital</fundingname>
      <fundingaddress>Charles St.
Launceston TAS 7250</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Tasmania</fundingname>
      <fundingaddress>Newnham Campus, Tas 7250</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Griffith University</fundingname>
      <fundingaddress>Nathan Campus QLD 4111</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>In Australia each year ten million intravenous (IV) drips are inserted in patients arms or in the backs of their hands to give fluid and medications.
Many drips are routinely replaced every few days in the hope that this reduces infection, however preliminary research suggests it would be better and more cost effective to leave them alone. That would save patients the pain of another needle as well as interruption to treatment. It would save doctors and nurses time, and reduce waste from plastic disposables. The research will provide the evidence to know one way or the other whether IV drips should be routinely changed or left alone.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Tasmanian State Research Ethics Committee</ethicname>
      <ethicaddress>Uni of Tasmania, Sandy Bay Campus
Hobart 7000 TAS</ethicaddress>
      <ethicapprovaldate>18/12/2006</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Prof Claire Rickard</name>
      <address>Griffith University
170 Kessels Road Nathan QLD 4111</address>
      <phone>07 3735 6460</phone>
      <fax />
      <email>c.rickard@griffith.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Prof Claire Rickard</name>
      <address>Griffith University
170 Kessels Rd, Nathan QLD 4111</address>
      <phone>07 3735 6460</phone>
      <fax />
      <email>c.rickard@griffith.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Prof Claire Rickard</name>
      <address />
      <phone />
      <fax />
      <email>c.rickard@griffith.edu.au</email>
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Claire Rickard</name>
      <address>Griffith University 170 Kessels Road Nathan QLD 4111</address>
      <phone>+61 7 3735 6460</phone>
      <fax />
      <email>c.rickard@griffith.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>